Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Outcomes among tuberculosis patients treated with a fixed-dose combination of four drugs are similar to those in patients treated with the same four…
NEW YORK (Reuters Health) – There is some evidence to support the use of immunosuppressive therapy to avoid relapse in inflammatory bowel disease (IBD), but more research is…
NEW YORK (Reuters Health) – Bosentan is not an effective therapy for patients with idiopathic pulmonary fibrosis (IPF), suggests a new study organized by the company that makes…
NEW YORK (Reuters Health) – Drug-related pneumonitis is a class-effect toxicity of mammalian target of rapamycin (mTOR) inhibitors and temsirolimus is no exception, new research confirms. In the…
NEW YORK (Reuters Health) – Among psychotropic agents administered to elderly patients for behavioral symptoms, atypical antipsychotics are safer than — or at least as safe as —…
WASHINGTON (from The George Washington University) – A new study by The George Washington University School of Medicine and Health Sciences, that will be published in the Journal…
NEW YORK (Reuters Health) – Long-term treatment with the atypical antipsychotic asenapine prevents relapse of schizophrenia and is well tolerated, according to a report in the Journal of…
NEW YORK (Reuters Health) – A review published by the Cochrane Library concludes that artesunate should replace quinine as the standard treatment for severe malaria. Dr. David Sinclair,…
NEW YORK (Reuters Health) – For patients with high platelet reactivity after percutaneous coronary intervention, treatment with a high-dose clopidogrel regimen does not improve outcomes compared with standard…
NEW YORK (Reuters Health) – For reducing pain from venipuncture in newborn infants, oral sucrose is more effective than topical liposomal lidocaine, according to the results of a…
